ANDA 90727, held by Epic Pharma LLC. Desoximetasone.
As of Nov 15, 2026, ANDA 90727 (Desoximetasone), held by Epic Pharma LLC, was first approved by FDA on Mar 10, 2011, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 10, 2011 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Desoximetasone0.05% ยท gel;topical | Desoximetasone | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
